Anne-Laure M. Le Ny
Research Subjects
Anne-Laure M. Le Ny has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Ethan Spencer
Intellectual Ventures Laboratory, Bellevue, Washington, USA
3 shared publications Nick Clute-Reinig
Intellectual Ventures Laboratory, Bellevue, USA
3 shared publicationsSpencer Garing
Intellectual Ventures Laboratory, Bellevue, USA
3 shared publications- Damian Madan
Global Health Labs, Inc. , Bellevue , WA 98007
2 shared publications Kevin P. Nichols
Intellectual Ventures Laboratory, Bellevue, USA
2 shared publicationsLuis F. Alonzo
Intellectual Ventures Laboratory, Bellevue, USA
2 shared publications
Latest Publications
- Open Access
- 12 February 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (2) , e0005937
NTDscope: A multi-contrast portable microscope for disease diagnosis
Accurate diagnostics are essential for disease control and elimination efforts. However, access to diagnostics for neglected tropical diseases (NTDs) is hindered by limited healthcare infrastructure in many NTD-endemic regions, as well as by reliance on time- and labor-intensive diagnostic methods, such as smear microscopy. New diagnostic tools that are portable, rapid, low-cost, and meet World Health Organization (WHO) sensitivity and specificity targets are urgently needed to accelerate NTD control and elimination programs. Here, we introduce the NTDscope, a portable microscopy platform that enables point-of-care imaging and automated detection of parasites and other pathogens in patient samples. The NTDscope builds on and extends the capabilities of the LoaScope, a device that turned the camera of a mobile phone into a microscope and used on-board image processing to automatically quantify Loa loa microfilariae burden in whole blood samples. The NTDscope replaces the mobile phone of the LoaScope with a system-on-module (SOM) that enables the integration of multiple imaging modalities in a single package designed to improve robustness and expand applications. In this work, we demonstrate the use of the NTDscope as a portable brightfield, darkfield, and fluorescence microscope for samples including microfilariae and helminth eggs. We also show that the device can be used to quantify molecular assays, such as a lateral flow test and a CRISPR-Cas13a-based assay. The ability to combine the diagnostic capabilities of conventional microscopy with molecular assays and machine learning in a single device could expand access to diagnostics for populations in NTD-endemic areas and beyond.
- 12 February 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (2) , e0005937
Open AccessNTDscope: A multi-contrast portable microscope for disease diagnosis
Accurate diagnostics are essential for disease control and elimination efforts. However, access to diagnostics for neglected tropical diseases (NTDs) is hindered by limited healthcare infrastructure in many NTD-endemic regions, as well as by reliance on time- and labor-intensive diagnostic methods, such as smear microscopy. New diagnostic tools that are portable, rapid, low-cost, and meet World Health Organization (WHO) sensitivity and specificity targets are urgently needed to accelerate NTD control and elimination programs. Here, we introduce the NTDscope, a portable microscopy platform that enables point-of-care imaging and automated detection of parasites and other pathogens in patient samples. The NTDscope builds on and extends the capabilities of the LoaScope, a device that turned the camera of a mobile phone into a microscope and used on-board image processing to automatically quantify Loa loa microfilariae burden in whole blood samples. The NTDscope replaces the mobile phone of the LoaScope with a system-on-module (SOM) that enables the integration of multiple imaging modalities in a single package designed to improve robustness and expand applications. In this work, we demonstrate the use of the NTDscope as a portable brightfield, darkfield, and fluorescence microscope for samples including microfilariae and helminth eggs. We also show that the device can be used to quantify molecular assays, such as a lateral flow test and a CRISPR-Cas13a-based assay. The ability to combine the diagnostic capabilities of conventional microscopy with molecular assays and machine learning in a single device could expand access to diagnostics for populations in NTD-endemic areas and beyond.
- Open Access
- 11 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Rapid, sensitive, and low-cost detection of Escherichia coli bacteria in contaminated water samples using a phage-based assay
Inadequate drinking water quality is among the major causes of preventable mortality, predominantly in young children. Identifying contaminated water sources remains a significant challenge, especially where resources are limited. The current methods for measuring Escherichia coli (E. coli), the WHO preferred indicator for measuring fecal contamination of water, involve overnight incubation and require specialized training. In 2016, UNICEF released a Target Product Profile (TPP) to incentivize product innovations to detect low levels of viable E. coli in water samples in the field in less than 6 h. Driven by this challenge, we developed a phage-based assay to detect and semi-quantify E. coli. We formulated a phage cocktail containing a total of 8 phages selected against an extensive bacterial strain library and recombined with the sensitive NanoLuc luciferase reporter. The assay was optimized to be processed in a microfluidic chip designed in-house and was tested against locally sourced sewage samples and on drinking water sources in Nairobi, Kenya. With this assay, combined with the microfluidic chip platform, we propose a complete automated solution to detect and semi-quantify E. coli at less than 10 MPN/100 mL in 5.5 h by minimally trained personnel.
- 11 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Open AccessRapid, sensitive, and low-cost detection of Escherichia coli bacteria in contaminated water samples using a phage-based assay
Inadequate drinking water quality is among the major causes of preventable mortality, predominantly in young children. Identifying contaminated water sources remains a significant challenge, especially where resources are limited. The current methods for measuring Escherichia coli (E. coli), the WHO preferred indicator for measuring fecal contamination of water, involve overnight incubation and require specialized training. In 2016, UNICEF released a Target Product Profile (TPP) to incentivize product innovations to detect low levels of viable E. coli in water samples in the field in less than 6 h. Driven by this challenge, we developed a phage-based assay to detect and semi-quantify E. coli. We formulated a phage cocktail containing a total of 8 phages selected against an extensive bacterial strain library and recombined with the sensitive NanoLuc luciferase reporter. The assay was optimized to be processed in a microfluidic chip designed in-house and was tested against locally sourced sewage samples and on drinking water sources in Nairobi, Kenya. With this assay, combined with the microfluidic chip platform, we propose a complete automated solution to detect and semi-quantify E. coli at less than 10 MPN/100 mL in 5.5 h by minimally trained personnel.
- Open Access
- 28 January 2022
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 22 (11) , 2155-2164
A microfluidic device and instrument prototypes for the detection of Escherichia coli in water samples using a phage-based bioluminescence assay
A phage-based microfluidic platform for highly sensitive and rapid detection of E. coli in low-resource settings.
- 28 January 2022
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 22 (11) , 2155-2164
Open AccessA microfluidic device and instrument prototypes for the detection of Escherichia coli in water samples using a phage-based bioluminescence assay
A phage-based microfluidic platform for highly sensitive and rapid detection of E. coli in low-resource settings.
- Open Access
- 17 September 2020
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 9 (38)
Genome Sequences of 38 Bacteriophages Infecting Escherichia coli, Isolated from Raw Sewage
Here, we report the complete genome sequences of 38 novel bacteriophages infecting Escherichia coli , isolated from a raw sewage source in Washington. Of these phages, 26 are under 100 kb, 11 are near 170 kb, and 1 352-kb jumbo phage was discovered.
- 17 September 2020
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 9 (38)
Open AccessGenome Sequences of 38 Bacteriophages Infecting Escherichia coli, Isolated from Raw Sewage
Here, we report the complete genome sequences of 38 novel bacteriophages infecting Escherichia coli , isolated from a raw sewage source in Washington. Of these phages, 26 are under 100 kb, 11 are near 170 kb, and 1 352-kb jumbo phage was discovered.